Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Nature

• Publication date

  1985-01-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/313231A0PMID 2982100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk.

  2005cited by this paper
• LHRH and Its Analogs

  1987cited by this paper
• Specific binding of luteinizing hormone releasing hormone to human luteal tissue.

  1984cited by this paper
• Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin.

  1984cited by this paper
• LHRH analogs for human mammary carcinoma

  1984cited by this paper
• Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro.

  1983cited by this paper
• Inhibition of hCG, alpha hCG and progesterone release from human placental tissue in vitro by a GnRH antagonist.

  1983cited by this paper
• Specific binding of luteinizing hormone releasing hormone to human luteal tissue

  1983cited by this paper
• Cellular aspects of the inhibitory actions of LH-RH on the ovary and testis.

  1982cited by this paper
• A new class of contraceptives?

  1982cited by this paper
• The chemical identity of the immunoreactive LHRH-like peptide biosynthesized in the human placenta.

  1982cited by this paper
• Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.

  1982cited by this paper
• Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist.

  1982cited by this paper
• A new class of contraceptives

  1982cited by this paper
• Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.

  1982cited by this paper
• From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents.

  1982cited by this paper
• Luteinizing hormone‐releasing factor increases release of human chorionic gonadotrophin in isolated cell columns of normal and malignant trophoblasts

  1982cited by this paper
• Extrapituitary actions of gonadotropin-releasing hormone.

  1981cited by this paper
• Human placental receptors for luteinizing hormone releasing hormone.

  1981cited by this paper
• Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect.

  1981cited by this paper
• Leydig cell receptors for luteinizing hormone releasing hormone and its agonists and their modulation by administration or deprivation of the releasing hormone.

  1980cited by this paper
• Identification of luteinizing hormone‐releasing factor and alpha subunit of glycoprotein hormones in ductal carcinoma of the mammary gland

  1980cited by this paper
• Cancer of the breast: the past decade (second of two parts).

  1980cited by this paper
• Cancer of the breast: the past decade (first of two parts).

  1980cited by this paper
• Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females.

  1980cited by this paper
• Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone.

  1980cited by this paper
• Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist.

  1979cited by this paper
• The effect of luteinizing hormone-releasing factor on human chorionic gonadotropin secretion.

  1978cited by this paper
• Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture.

  1977cited by this paper
• Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on 7, 12- dimethylbenz (a)anthracene-induced rat mammary tumors. Histological and endocrine studies.

  1977cited by this paper
• Regression of rat mammary tumors effected by a gonadoliberin analog.

  1976cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper
• Oestrogen-responsive human breast cancer in long term tissue culture

  1975cited by this paper

• Topoisomeric Membrane-Active Peptides: A Review of the Last Two Decades

  2023cites this paper
• GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females

  2023cites this paper
• Evolving strategies and application of proteins and peptide therapeutics in cancer treatment.

  2023cites this paper
• Peptide‐based diagnostic and therapeutic agents: Where we are and where we are heading?

  2022cites this paper
• Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer

  2021cites this paper
• Mammary gland-specific regulation of GNRH and GNRH-receptor gene expression is likely part of a local autoregulatory system in female vizcachas (Rodentia: Chinchillidae).

  2020cites this paper
• Warburg Effect Inversion: Adiposity shifts central primary metabolism in MCF‐7 breast cancer cells

  2019cites this paper
• Evaluating triptorelin as a treatment option for breast cancer

  2019cites this paper
• Structure-activity relationship studies of Longicalcynin A analogues, as anticancer cyclopeptides.

  2019cites this paper
• Anti-cancer effect of GV1001 for prostate cancer; function as a ligand of GnRHR.

  2019cites this paper
• Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs

  2019cites this paper
• Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification

  2018cites this paper
• Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer

  2018cites this paper
• Activation of human gonadotropin-releasing hormone receptor promotes down regulation of ARHGAP18 and regulates the cell invasion of MDA-MB-231 cells.

  2018cites this paper
• Targeting luteinizing hormone‐releasing hormone: A potential therapeutics to treat gynecological and other cancers

  2018cites this paper
• Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases.

  2018cites this paper
• The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis

  2017cites this paper
• Human Milk Microbiome: A Perspective to Healthy and Infected Individuals

  2017cites this paper
• Somatic Cell Count: A Human Breast Wellbeing Indicator.

  2017cites this paper
• Gonadotropin-Releasing Hormones

  2016cites this paper
• Development of a 68Ga-peptide tracer for PET GnRH1-imaging

  2016cites this paper
• Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells

  2016cites this paper
• Development of a Ga-68 labeled triptorelin analog for GnRH receptor imaging

  2016cites this paper
• Gonadotropin-releasing hormone agonist

  2015cites this paper
• Comparative in vitro biological evaluation of daunorubicin containing GnRH‐I and GnRH‐II conjugates developed for tumor targeting

  2015cites this paper
• Beyond peptides and mAbs—current status and future perspectives for biotherapeutics with novel constructs

  2015cites this paper
• Towards a non-animal risk assessment for anti-androgenic effects in humans.

  2015cites this paper
• The Role of Adhesion in Gold Nanoparticles for Cancer Detection and Treatment

  2015cites this paper
• Structures, Functions and Expressions of GnRH and GnRH Receptor in Peripheral Reproductive Organs and Their Regulation by Estradiol-17β

  2015cites this paper
• Gold nanoparticles for cancer detection and treatment: The role of adhesion

  2014cites this paper
• Modulation of proliferation by gonadotropin-releasing hormone receptors in breast cancer cells

  2014cites this paper
• GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor.

  2014cites this paper
• The Functionality of Peptides and Cancer

  2014cites this paper
• Tumor-targeting peptides and small molecules as anti-cancer agents to overcome drug resistance.

  2014cites this paper
• Gonadotropin-releasing hormone neuropeptides and receptor in human breast cancer: correlation to poor prognosis parameters.

  2013cites this paper
• Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides.

  2013cites this paper
• Regulation of the cell proliferation and migration as extra-pituitary functions of GnRH.

  2013cites this paper
• Leuprorelin Acetate Long-Lasting Effects on GnRH Receptors of Prostate Cancer Cells: An Atomic Force Microscopy Study of Agonist/Receptor Interaction

  2013cites this paper
• Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation

  2012cites this paper
• Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.

  2012cites this paper
• Quantitation of slow release triptorelin in beagle dog plasma by liquid chromatography-tandem mass spectrometry.

  2012cites this paper
• GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies.

  2012cites this paper
• Cancer Treatment Using Peptides: Current Therapies and Future Prospects

  2012cites this paper
• Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231

  2012cites this paper
• Characterisation of the direct antiproliferative effects of a gonadotrophin-releasing hormone analogue

  2012influential citation
• Review of its Pharmacodynamic and Pharmacokinetic Properties , and Clinical Use in Sex Hormone-Related Conditions

  2012cites this paper
• GnRH Agonists and Antagonists

  2012cites this paper
• Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.

  2011cites this paper
• Leuprorelin acetate affects adhesion molecule expression in human prostate cancer cells.

  2011cites this paper
• Endocrine Therapies in Breast and Prostate Cancer

  2011influential citation
• Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.

  2011cites this paper
• Stem cell transplantation: Current and prospective therapies to treat leukaemia

  2011cites this paper
• Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer

  2010cites this paper
• Up-regulation of apoptosis by gonadotrophin-releasing hormone agonist in cultures of endometrial cells from women with symptomatic myomas.

  2010cites this paper
• Development of [111In]-DTPA-buserelin for GnRH receptor studies

  2010cites this paper
• Dissection of GnRH receptor-G protein coupling

  2009cites this paper
• The effect of GnRH on in vitro bovine myometrial activity.

  2009cites this paper
• Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (Review).

  2009cites this paper
• Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.

  2009cites this paper
• New derivatives of GnRH as potential anticancer therapeutic agents.

  2008cites this paper
• A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition.

  2008cites this paper
• Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.

  2008cites this paper
• 589 POSTER Functional evaluation of members of the LIV-1 family of proteins and their role in breast cancer

  2008cites this paper
• Preparation and biodistribution of [67Ga]-DTPA-gonadorelin in normal rats

  2008cites this paper
• GnRH analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand- induced-selective-signalling

  2008cites this paper
• Gonadotropin‐releasing hormone: GnRH receptor signaling in extrapituitary tissues

  2008cites this paper
• A Crucial Role for G (cid:1) q/11 , But Not G (cid:1) i/o or G (cid:1) s , in Gonadotropin-Releasing Hormone Receptor-Mediated Cell Growth Inhibition

  2008cites this paper
• Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.

  2008cites this paper
• GnRH analogues containing conformationally restricted amino acids in positions 3 and 6: differential impact on pituitary binding affinity and direct antiproliferative effect on breast cancer cells†

  2008cites this paper
• Diversity of actions of GnRHs mediated by ligand-induced selective signaling.

  2008cites this paper
• Antiproliferative Effects of GnRH Agonists: Prospects and Problems for Cancer Therapy

  2008cites this paper
• LHRH Conjugated Magnetic Nanoparticles for Diagnosis and Treatment of Cancers

  2007cites this paper
• Cross-talk between gonadotropin-releasing hormones and progesterone receptor in neuroendocrine cells

  2007cites this paper
• [Effect of an LH-RH analogue on adhesion molecules in human prostate cancer cells].

  2007cites this paper
• Synthesis and Biological Evaluation of New GnRH Analogues on Pituitary and Breast Cancer Cells

  2007cites this paper
• The Role of the Hypothalamus-Pituitary-Gonadal Axis in Breast Cancer: a candidate gene approach

  2007cites this paper
• Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone

  2007cites this paper
• Searching for the optimal GnRH antagonist regimen to compare with GnRH agonists in IVF

  2007cites this paper
• Human myometrium and leiomyomas express gonadotropin-releasing hormone 2 and gonadotropin-releasing hormone 2 receptor.

  2007cites this paper
• Effetti del leuprorelin acetato sulla espressione di alcune molecole di adesione in cellule di carcinoma prostatico umano

  2007cites this paper
• GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients

  2007cites this paper
• Gonadotropin-Releasing Hormone Functionally Antagonizes Testosterone Activation of the Human Androgen Receptor in Prostate Cells through Focal Adhesion Complexes Involving Hic-5

  2007cites this paper
• Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?

  2006cites this paper
• MDA-MB-231 and ZR-751 Breast Carcinoma Cell Lines Gonadotropin-releasing Hormone Gene Expression in Updated Version

  2006influential citation
• gonadotropin-releasing hormone analogues

  2006cites this paper
• Avaliação do tratamento hormonal e/ou intervencionista por punção nos tumores císticos de ovários

  2006cites this paper
• GnRH analogs reduce invasiveness of human breast cancer cells

  2006cites this paper
• Gonadotropin-releasing Hormone Gene Expression in MDA-MB-231 and ZR-751 Breast Carcinoma Cell Lines '

  2006cites this paper
• The mammalian type II gonadotropin-releasing hormone receptor : cloning, distribution and role in gonadotropin gene expression

  2006cites this paper
• Wild blueberry (Vaccinium angustifolium) consumption affects the composition and structure of glycosaminoglycans in Sprague-Dawley rat aorta.

  2006cites this paper
• Autocrine-inhibitory LHRH Loop Prostate Cancer Cell Line DU 145: Evidence for an Hormone (LHRH) Agonists on Human Androgen-independent Antiproliferative Effects of Luteinizing Hormone-releasing

  2006cites this paper
• Signal Transduction of GnRH Tract Tumor Receptor in the Reproduct ive

  2006cites this paper
• Autocrine-inhibitory LHRH Loop Prostate Cancer Cell Line DU 145 : Evidence for an Hormone ( LHRH ) Agonists on Human Androgen-independent Antiproliferative Effects of Luteinizing Hormone-releasing

  2006cites this paper
• Dependence of GnRH‐induced phosphorylation of CREB and BAD on EGF receptor transactivation in GT1‐7 neuronal cells

  2006cites this paper
• Regulation of Fanconi anaemia complementation group a (Fanca) by gonadotropin releasing hormone : a role for Fanca in reproduction

  2005cites this paper
• Expression of the estrogen receptor gene in developing and adult human breast

  2005cites this paper
• Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma

  2005cites this paper
• Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma

  2005cites this paper
• The Role of Ovarian Ablation in the Management of Breast Cancer

  2005cites this paper
• Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[a]anthracene-induced mammary carcinoma: studies with slow-release formulations

  2005cites this paper